[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342258-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-342258-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","small-molecule-with-big-impact-review-metarrestin-targets-the-perinucleolar-compartment-in-cancer-metastasis","Small Molecule with Big Impact - Review - Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis","","Metarrestin (ML246) is a first-in-class pyrrole–pyrimidine-derived small molecule that selectively targets the perinucleolar compartment (PNC), a distinct subnuclear structure enriched in solid tumor cells. PNC abundance correlates with malignancy and serves as an indicator of tumor aggressiveness, progression, and metastasis. Building on preclinical evidence, metarrestin is advanced toward first-in-human evaluation. This review synthesizes PNC structure and function, summarizes metarrestin findings across in vitro, in vivo, and clinical studies, and highlights its pharmaceutical relevance as a promising anticancer candidate.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/small-molecule-with-big-impact-review-metarrestin-targets-the-perinucleolar-compartment-in-cancer-metastasis/342258/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/small-molecule-with-big-impact-review-metarrestin-targets-the-perinucleolar-compartment-in-cancer-metastasis/342258.png","ImageObject",300,407,{"name":42,"@type":43},"Theodora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":33},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"What is metarrestin (ML246) and what does it target?","Question",{"text":62,"@type":63},"Metarrestin (ML246) is a small molecule designed to selectively target the perinucleolar compartment (PNC). The review describes PNC as a subnuclear structure enriched in solid tumor cells.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"Why is the perinucleolar compartment (PNC) important in cancer metastasis?",{"text":67,"@type":63},"PNC prevalence is associated with malignancy and correlates with tumor aggressiveness, progression, and metastasis. It is enriched in small nuclear RNAs, RNA-binding proteins, and is linked to Pol III-related RNA metabolism.",{"name":69,"@type":60,"acceptedAnswer":70},"What evidence supports metarrestin as a potential anticancer therapy?",{"text":71,"@type":63},"The review summarizes preclinical results and translational progress, including studies across in vitro, in vivo, and human clinical trial research. It also reports molecular docking and MD simulations indicating strong, stable binding to eEF1A1 and eEF1A2.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},342258,1790045944,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":33,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":79,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","Review  \nSmall Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis  \nVivek K. Kashyap 1,2,*, Bhuvnesh P. Sharma 3, Divya Pandey 4, Ajay K. Singh 5, Godwin Peasah-Darkwah 1,2, Bhupesh Singh 6, Kuldeep K. Roy 4, Murali M. Yallapu 1,2 and Subhash C. Chauhan 1,2, *  \nCitation: Kashyap, V.K.; Sharma,  \nB.P.; Pandey, D.; Singh, A.K.; Peasah-Darkwah, G.; Singh, B.; Roy,  \nK.K.; Yallapu, M.M.; Chauhan, S.C. Small Molecule with Big Impact: Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis. Cells 2024, 13, 2053. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/cells13242053](10.3390/cells13242053)  \nAcademic Editors: Daria A.  \nChudakova and Kazuyuki Kitatani  \nReceived: 4 September 2024  \nRevised: 1 December 2024  \nAccepted: 2 December 2024  \nPublished: 12 December 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Division of Cancer Immunology and Microbiology, Medicine, and Oncology Integrated Service Unit, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA  \n2 South Texas Center of Excellence in Cancer Research (ST-CECR), McAllen, TX 78504, USA  \n3 Department of Biotechnology, Bhagwant University, Ajmer 305004, Rajasthan, India  \n4 Department of Pharmaceutical Sciences, School of Health Sciences and Technology, UPES, Dehradun 248007, Uttarakhand, India  \n5 Department of Oncology, Albert Einstein College of Medicine, Bronx, NY 10461, USA  \n6 School of Applied Sciences, OM Sterling Global University, Hisar 125001, Haryana, India  \n* [Correspondence: vivek.kashyap@utrgv.edu](Correspondence: vivek.kashyap@utrgv.edu) (V.K.K.); [subhash.chauhan@utrgv.edu](subhash.chauhan@utrgv.edu) (S.C.C.); Tel.: +1-956-296-1738 (V.K.K.); +1-956-296-500 (S.C.C.)  \nAbstract: Metarrestin (ML246) is a first-in-class pyrrole–pyrimidine-derived small molecule that selectively targets the perinucleolar compartment (PNC) . PNC is a distinct subnuclear structure predominantly found in solid tumor cells. The occurrence of PNC demonstrates a positive correlation with malignancy, serving as an indicator of tumor aggressiveness, progression, and metastasis. Various promising preclinical results have led to the clinical translation of metarrestin into a firstin-human trial. This review aims to summarize (i) the current understanding of the structure and function of PNC and its role in cancer progression and metastasis,(ii) key findings from studies examining the effect of metarrestin on various cancers across the translational spectrum, including in vitro, in vivo, and human clinical trial studies, and (iii) the pharmaceutical relevance of metarrestin as a promising anticancer candidate. Furthermore, our molecular docking and MD simulation studies show that metarrestin binds to eEF1A1 and eEF1A2 with a strong and stable affinity and inhibitseEF1A2 more efficiently compared to eEF1A1 . The promising results from preclinical studies suggest that metarrestin has the potential to revolutionize the treatment of cancer, heralding a paradigm shift in its therapeutic management.  \nKeywords: Perinucleolar compartment (PNC); RNA polymerase III transcripts; metarrestin; cancer metastasis; eEF1A1; eEF1A2; pharmacokinetic/toxic properties (ADME/T)  \n1. Introduction  \nCancer is a major public health problem worldwide and is the second leading cause of death in the United States [1] . Malignant tumors are characterized by uncontrolled cellular proliferation and the potential to evade surrounding tissues [2] . These tumors may spread to other regions of the body through a process known as metastasis [2] . Metastasis is a multistage and intricate process by wh","cbCaih74cjKTzJoQ","https://ap.wps.com/l/cbCaih74cjKTzJoQ","pdf",3602264,17,"English","# Abstract\n# Introduction\n## Metastasis as a multi-stage process\n## PNC as a phenotypic biomarker\n# Metarrestin and targeting of PNC","[{\"question\":\"What is metarrestin (ML246) and what does it target?\",\"answer\":\"Metarrestin (ML246) is a small molecule designed to selectively target the perinucleolar compartment (PNC). The review describes PNC as a subnuclear structure enriched in solid tumor cells.\"},{\"question\":\"Why is the perinucleolar compartment (PNC) important in cancer metastasis?\",\"answer\":\"PNC prevalence is associated with malignancy and correlates with tumor aggressiveness, progression, and metastasis. It is enriched in small nuclear RNAs, RNA-binding proteins, and is linked to Pol III-related RNA metabolism.\"},{\"question\":\"What evidence supports metarrestin as a potential anticancer therapy?\",\"answer\":\"The review summarizes preclinical results and translational progress, including studies across in vitro, in vivo, and human clinical trial research. It also reports molecular docking and MD simulations indicating strong, stable binding to eEF1A1 and eEF1A2.\"}]","Small Molecule with Big Impact - Review - Metarrestin Targets the Perinucleolar Compartment in Cancer Metastasis | PDF",43,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/befa701b4c1b2bbd973de5fe5a1dc4ed.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78fbe6d5199ae83a4c034b004e62f272.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff2095e3986b0665d7ac45d373bb3d39.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8feff008557409162b63dd4d694ca788.webp",980,1385]